Yan Limei, Lu Xiajun, Wang Ning, Jia Peng
Intensive Care Medicine Department, The People's Hospital of Suzhou New District, Suzhou, China.
Trauma Orthopedics, The People's Hospital of Suzhou New District, Suzhou, China.
PeerJ. 2025 May 13;13:e19404. doi: 10.7717/peerj.19404. eCollection 2025.
Circular ribonucleic acid (RNA) protein kinase C iota (circ-PRKCI, hsa_circRNA_0122683) has been previously reported to be involved in the development of sepsis. However, the knowledge regarding the potential role and mechanism of circ-PRKCI in sepsis-induced acute lung injury (ALI) is unclear. An cellular model of sepsis-ALI was simulated by the treatment of lipopolysaccharide (LPS) in human pulmonary alveolar epithelial cells (HPAEpiCs). The expression of circ-PRKCI in plasma samples from sepsis patients with or without ALI as well as sepsis-ALI cell model was determined by quantitative real-time PCR (qRT-PCR). The diagnostic utility of circ-PRKCI was analyzed using receiver operating characteristic (ROC) curves. The levels of iron content (Fe), glutathione (GSH), malondialdehyde (MDA), and reactive oxygen species (ROS) were detected using corresponding commercial kits. The assessment of cell viability and production of pro-infammatory cytokines (IL-6, IL-1β and TNF-α) was measured using Cell Counting Kit-8 (CCK-8) and enzyme-linked immunosorbent assay (ELISA). The targeting relationship between circ-PRKCI and miR-382-5p was predicted by bioinformatics analysis, and subsequently confirmed by luciferase reporter and RNA immunoprecipitation (RIP) assays. Results shows that decreased circ-PRKCI expression but increased miR-382-5p expression was observed in sepsis patients with ALI and sepsis-induced ALI cell model. The area under the curve values of ROC curves for circ-PRKCI in differentiating septic ALI patients from healthy individuals and septic non-ALI patients were 0.996 and 0.999, respectively. Functional assays revealed that enforced expression of circ-PRKCI alleviated LPS-induced ferroptosis and inflammatory response of HPAEpiCs, which were reversed by Erastin or FIN56 administration. Mechanistically, circ-PRKCI was identified as a sponge of miR-382-5p and negatively regulated miR-382-5p expression. Further rescue experiments showed that miR-382-5p overexpression could compromise the anti-ferroptosis and anti-inflammatory response effects of circ-PRKCI on LPS-induced injury of HPAEpiCs. Our study demonstrated that circ-PRKCI may be a promising biomarker for septic ALI diagnosis. circ-PRKCI inhibits ferroptosis and inflammatory response in sepsis-induced ALI by sponging miR-382-5p, indicating that the circ-PRKCI/miR-382-5p axis might be a novel therapeutic target for the treatment of sepsis-induced ALI.
环状核糖核酸(RNA)蛋白激酶Cι(circ-PRKCI,hsa_circRNA_0122683)此前已被报道参与脓毒症的发展。然而,关于circ-PRKCI在脓毒症诱导的急性肺损伤(ALI)中的潜在作用和机制尚不清楚。通过在人肺泡上皮细胞(HPAEpiCs)中用脂多糖(LPS)处理来模拟脓毒症-ALI的细胞模型。通过定量实时PCR(qRT-PCR)测定脓毒症合并或不合并ALI患者血浆样本以及脓毒症-ALI细胞模型中circ-PRKCI的表达。使用受试者工作特征(ROC)曲线分析circ-PRKCI的诊断效用。使用相应的商业试剂盒检测铁含量(Fe)、谷胱甘肽(GSH)、丙二醛(MDA)和活性氧(ROS)的水平。使用细胞计数试剂盒-8(CCK-8)和酶联免疫吸附测定(ELISA)测量细胞活力和促炎细胞因子(IL-6、IL-1β和TNF-α)的产生。通过生物信息学分析预测circ-PRKCI与miR-382-5p之间的靶向关系,随后通过荧光素酶报告基因和RNA免疫沉淀(RIP)试验进行验证。结果显示,在脓毒症合并ALI患者和脓毒症诱导的ALI细胞模型中,观察到circ-PRKCI表达降低但miR-382-5p表达增加。circ-PRKCI在区分脓毒症ALI患者与健康个体和脓毒症非ALI患者时,ROC曲线下面积值分别为0.996和0.999。功能试验表明,circ-PRKCI的过表达减轻了LPS诱导的HPAEpiCs的铁死亡和炎症反应,而埃拉斯汀或FIN56给药可逆转这些反应。机制上,circ-PRKCI被鉴定为miR-382-5p的海绵,并负向调节miR-382-5p的表达。进一步的拯救实验表明,miR-382-5p的过表达可能会削弱circ-PRKCI对LPS诱导的HPAEpiCs损伤的抗铁死亡和抗炎反应作用。我们的研究表明,circ-PRKCI可能是脓毒症ALI诊断的一个有前景的生物标志物。circ-PRKCI通过海绵吸附miR-382-5p抑制脓毒症诱导的ALI中的铁死亡和炎症反应,表明circ-PRKCI/miR-382-5p轴可能是治疗脓毒症诱导的ALI的一个新的治疗靶点。